| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.8B | $2.6B | $2.5B | $14.5B | $13.9B | $12.6B | $10.3B | $8.4B |
| Cost of Revenue | $6.7B | $6.3B | $6.1B | $8.8B | $8.7B | $8.3B | $6.6B | $5.6B |
| Gross Profit | $1.1B | $1.0B | $1.0B | $5.7B | $5.2B | $4.2B | $3.7B | $2.9B |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | $2.3B | $2.2B | $2.1B | $4.1B | $3.9B | $3.5B | $2.7B | $1.3B |
| Operating Income | $0.5B | $0.5B | $0.3B | $-16.1B | $1.1B | $0.6B | $1.0B | $1.5B |
| Net Income | $0.5B | $0.3B | $0.3B | $-16.7B | $0.4B | $0.2B | $0.3B | $0.8B |
| EPS (Basic) | $0.73 | $2.62 | $-11.26 | $-27.68 | $0.68 | $0.26 | $0.67 | $2.58 |
| EPS (Diluted) | $0.73 | $2.61 | $-11.26 | $-27.68 | $0.67 | $0.25 | $0.66 | $2.55 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $33.5B | $33.8B | $55.1B | $63.3B | $82.9B | $83.8B | $83.8B | $23.8B |
| Current Assets | $4.5B | $5.2B | $13.8B | $12.8B | $10.7B | $9.9B | $8.7B | $3.7B |
| Cash & Equivalents | $0.6B | $0.8B | $0.4B | $2.2B | $2.0B | $2.0B | $1.2B | $0.7B |
| Total Liabilities | $19.6B | $18.1B | $36.0B | $35.9B | $35.4B | $34.4B | $34.4B | $13.5B |
| Current Liabilities | $7.6B | $6.1B | $18.3B | $16.2B | $14.5B | $12.4B | $10.4B | $3.1B |
| Stockholders' Equity | $13.9B | $15.7B | $19.1B | $27.2B | $47.3B | $49.3B | $49.4B | $10.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | — | — | $4.3B | $3.9B | $4.8B | $4.4B | $2.4B | $2.0B |
| Investing Cash Flow | — | — | $-1.4B | $-0.4B | $-1.8B | $-0.9B | $-7.5B | $-0.7B |
| Capital Expenditures | $0.2B | $0.1B | $0.1B | $0.3B | $0.3B | $0.3B | $0.2B | $0.1B |
| Financing Cash Flow | — | — | $-3.5B | $-2.6B | $-2.5B | $-2.8B | $7.6B | $-1.2B |